Skip to main content
SpringerLink
Log in

Psychotic Disorders and Substance Use Disorders

  • Reference work entry
  • First Online:
Textbook of Addiction Treatment: International Perspectives

  • 257 Accesses

Abstract

The comorbidity of psychotic and substance use disorders (SUDs) is a major issue in mental health because of its high frequency and poor prognosis. Moreover, it is often neglected both for the difficulty to assess SUDs in psychotic patients and for scarce attitude to evaluate and treat substance misuse by psychiatric service staff. On the other hand, psychotic patients with SUDs can receive inadequate treatment for psychosis by SUD services for similar reasons.

Assessing and treating this comorbidity require the knowledge and the integration of specific tools and interventions that should be tailored toward patients’ clinical condition and that can be difficult to manage in daily clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 339.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Addington J, Duchak V (1997) Reasons for substance use in schizophrenia. Acta Psychiatr Scand 96:329–333

    Article  CAS  PubMed  Google Scholar 

  • Alverson H, Alverson M, Drake RE (2000) An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness. Community Ment health J 36(6):557–569

    Article  CAS  PubMed  Google Scholar 

  • Alverson H, Alverson M, Drake RE (2001) Social patterns of substance-use among people with dual diagnosis. Ment Health Serv Res 3(1):3–14

    Article  CAS  PubMed  Google Scholar 

  • American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, DSM-IV-TR, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Angold A, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiat 40(1):57–87

    Article  CAS  PubMed  Google Scholar 

  • Aoki Y, Orikabe L, Takayanagi Y, Yahata N, Mozue Y, Sudo Y, Ishii T, Itokawa M, Suzuki M, Kurachi M, Okazaki Y, Kasai K, Yamasue H (2013) Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis. Schizophr Res 147(2-3):355–361

    Google Scholar 

  • Bossong MG, Niesink RJM (2010) Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92:370–385

    Article  CAS  PubMed  Google Scholar 

  • Brady KT, Sinha R (2005) Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 162:1483–1493

    Article  PubMed  Google Scholar 

  • Carrà G, Johnson S (2009) Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK – a systematic review. Soc Psychiatry Psychiatr Epidemiol 44:429–447

    Article  PubMed  Google Scholar 

  • Carrà G, Johnson S, Bebbington P, Angermeyer MC, Heider D, Brugha T, Azorin JM, Toumi M (2012) The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci 262:607–616

    Article  PubMed  Google Scholar 

  • Center for Substance Abuse Treatment (2005) Substance abuse treatment for persons with co-occurring disorders. Substance Abuse and Mental Health Service Administration, Rockville

    Google Scholar 

  • Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50(2):71–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chow CM, Wieman D, Cichocki B, Qvicklund H, Hiersteiner D (2013) Mission impossible: treating serious mental illness and substance use co-occurring disorder with integrated treatment: a meta-analysis. Ment Health Subst Use 6(2):150–168

    Article  Google Scholar 

  • Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G (2008) Psychosocial interventions for people with both severe mental illness and substance misuse (review). Cochrane Database Syst Rev 2008, Issue 1. Art. No.:CD001088. DOI: 10.1002/14651858.CD001088.pub2

    Google Scholar 

  • Cloninger CR, Svrakic DM (2009) Personality disorders. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan & Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2197–2240

    Google Scholar 

  • Coyle JT (2006) Substance use disorders and schizophrenia: a question of shared glutamatergic mechanisms. Neurotox Res 10(3):221–233

    Article  CAS  PubMed  Google Scholar 

  • Cuffel BJ, Chase P (1994) Remission and relapse of substance use disorders in schizophrenia: results from a one-year prospective study. J Nerv Ment Dis 182:342–348

    Article  CAS  PubMed  Google Scholar 

  • D’souza DC, Sewell RA, Ranganathan M (2009) Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259(7):413–431

    Article  PubMed Central  PubMed  Google Scholar 

  • Degenhardt L, Hall W, Lynskey M (2003) Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 71(1):37–48

    Article  PubMed  Google Scholar 

  • Dixon L (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 35:S93–S100

    Article  PubMed  Google Scholar 

  • Drake RE, Osher FC, Wallach MA (1989) Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Ment Dis 177:408–414

    Article  CAS  PubMed  Google Scholar 

  • Drake RE, Alterman AI, Rosenberg SR (1993) Detection of substance use disorder in severely mentally ill patients. Community Ment Health J 29(2):175–192

    Article  CAS  PubMed  Google Scholar 

  • Drake RE, Mueser KT, Brunette MF, McHugo GJ (2004) A review of treatments for people with severe mental illness and co-occurring substance use disorders. Psychiatr Rehabil J 27(4):360–374

    Article  PubMed  Google Scholar 

  • Drake RE, O’Neal EL, Wallach MA (2008) A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Substs Abus Treat 34:123–138

    Article  Google Scholar 

  • El-Guebaly N, Hodgins DC (1992) Schizophrenia and substance abuse: prevalence issues. Can J Psychiat 37:704–710

    CAS  Google Scholar 

  • Eurostat (2011) EU27 population 502.5 million at 1 January 2011. Eurostat news release 110/2011. Eurostat Press Office. http://ec.europa.eu/eurostat. Accessed 3 Jun 2013

  • Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 7:113–139

    Article  PubMed Central  PubMed  Google Scholar 

  • Green AI (2006) Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches. J Clin Psychiatry 67(Suppl 7):31–35

    PubMed  Google Scholar 

  • Gual A (2007) Dual diagnosis in Spain. Drug Alcohol Rev 26:65–71

    Article  PubMed  Google Scholar 

  • Harrison I, Joyce EM, Mutsatsa SH, Hutton SB, Huddy V, Kapasi M, Barnes TRE (2008) Naturalistic follow-up of co-morbid substance in schizophrenia: the West London first-episode study. Psychol Med 38:79–88

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Horsfall J, Cleary M, Hunt GE, Walter G (2009) Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv Rev Psychiatry 17:24–34

    Article  PubMed  Google Scholar 

  • Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D (2002) Substance misuse in patients with schizophrenia. Drugs 62(5):743–755

    Article  PubMed  Google Scholar 

  • Keshavan MS, Kaneko Y (2013) Secondary psychoses: an update. World Psychiatry 12:4–15

    Article  PubMed Central  PubMed  Google Scholar 

  • Kessler RC (2004) The epidemiology of dual diagnosis. Biol Psychiatry 56:730–737

    Article  PubMed  Google Scholar 

  • Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Franck RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66(1):17–31

    Article  CAS  PubMed  Google Scholar 

  • Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J of Psych 142:1259–1264

    Article  CAS  Google Scholar 

  • Khantzian EJ (1997) The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiat 4:231–244

    Article  CAS  Google Scholar 

  • Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK (2004) Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 74:115–122

    Article  PubMed  Google Scholar 

  • Kirow G, Owen MJ (2009) Genetics of schizophrenia. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan & Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1462–1475

    Google Scholar 

  • Krystal JH, D’Souza DC, Madonick S, Petrakis IL (1999) Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizoph Res 35:S35–S49

    Google Scholar 

  • Krystal JH, D’Souza DC, Gallinat J, Driesen N, Abi-Dargham A, Petrakis I, Heinz A, Pearlson G (2006) The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 10(3,4):235–252

    Article  CAS  PubMed  Google Scholar 

  • Kuepper R, Morrison PD, van Os J, Murray RM, Kenis G, Henquet C (2010) Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res 121:107–117

    Article  PubMed  Google Scholar 

  • Large M, Sharma S, Compton MT, Slade T, Nielssen O (2011) Cannabis use and earlier onset of psychosis. Arch Gen Psychiatry 68(6):555–561

    Article  PubMed  Google Scholar 

  • Lev-Ran S, Imtiaz S, Le Foll B (2012) Self-reported psychotic disorders among individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Addict 21(6):531–535

    Article  PubMed  Google Scholar 

  • Lingford-Hughes AR, Welch S, Peters L, Nutt DJ (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 26(7):899–952

    Article  CAS  PubMed  Google Scholar 

  • McCann UD, Ricaurte GA (2009) Amphetamine (or amphetamine-like) related disorders. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan & Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1288–1295

    Google Scholar 

  • Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319–328

    Article  PubMed  Google Scholar 

  • Morojele NK, Saban A, Seedat S (2012) Clinical presentations and diagnostic issues in dual diagnosis disorders. Curr Opin Psychiatry 25:181–186

    Article  PubMed  Google Scholar 

  • National Collaboratory Centre for Mental Health (2011) Psychosis with coexisting substance misuse – assessment and management in adults and young people – the NICE guideline on assessment and management in adults and young people. The British Psychological Society, Leicester

    Google Scholar 

  • Niemi-Pynttäri JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP (2013) Substance-induced psychoses converting into schizophrenia: a register-based study of 18478 Finnish inpatient cases. J Clin Psychiatry 74(1):e94–e99

    Article  PubMed  Google Scholar 

  • Noordsy DL, Green AI (2003) Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Curr Psychiatry Rep 5(5):340–346

    Article  PubMed  Google Scholar 

  • Palomo T, Archer T, Kostrzewa RM, Beninger R (2007) Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res 12(1):17–27

    Article  CAS  PubMed  Google Scholar 

  • Potvin S, Sepehry AA, Stip E (2006) A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 36:431–440

    Article  PubMed  Google Scholar 

  • Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, McKnight-Eily LR, Harrison L, D’Angelo DV, Williams L, Morrow B, Gould D, Safran MA (2011) Mental illness surveillance among adults in the United States. Morbidity and Mortality Weekly Report – Supplement/Vol. 60

    Google Scholar 

  • Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264:2511–2518

    Article  CAS  PubMed  Google Scholar 

  • Rietdijk J, Hogerzeil SJ, van Hemert AM, Cuijpers P, Linszen DH, van der Gaag M (2011) Pathways to psychosis: help-seeking behavior in the prodromal phase. Schizophr Res 132:213–219

    Article  PubMed  Google Scholar 

  • Rocchetti M, Crescini A, Borgwardt S, Caverzasi E, Politi P, Atakan Z, Fusar-Poli P (2013) Is cannabis neurotoxic for the healthy brain? A metaanalytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci 67(7):483–492

    Google Scholar 

  • Ross S, Peselow E (2012) Co-occurring psychotic and addictive disorders: neurobiology and diagnosis. Clin Neuropharmacol 35(5):235–243

    Article  PubMed  Google Scholar 

  • Samet S, Nunes EV, Hasin D (2004) Diagnosing comorbidity: concepts, criteria and methods. Acta Neuropsychiatr 16:9–18

    Article  Google Scholar 

  • San L, Arranz B, Martinez-Raga J (2007) Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders. Eur Addict Res 13(4):230–243

    Article  PubMed  Google Scholar 

  • Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, McCormack J, Lorell BS, Kane J (2010) Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophr Res 120(1–3):101–107

    Article  PubMed Central  PubMed  Google Scholar 

  • Soyka M, Albus M, Immler B, Kathmann N, Hippius H (2001) Psychopathology in dual diagnosis and non-addicted schizophrenics: are there differences? Eur Arch Psychiatry Clin Neurosci 251:232–238

    Article  CAS  PubMed  Google Scholar 

  • Strain EC, Anthony JC (2009) Substance-related disorders – introduction and overview. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan & Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1237–1268

    Google Scholar 

  • Substance Abuse and Mental Health Service Administration (2012) Results from the 2011 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-44, HHS Publication No. (SMA) 12 – 4713. Substance Abuse and Mental Health Service Administration, Rockville

    Google Scholar 

  • Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait. Arch Gen Psychiatry 60:1187–1192

    Article  PubMed  Google Scholar 

  • Van Os J, Allardyce J (2009) The clinical epidemiology of schizophrenia. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1475–1487

    Google Scholar 

  • Volkow ND (2009) Substance use disorders in schizophrenia – clinical implications of comorbidity. Schizophr Bull 35(3):469–472

    Article  PubMed Central  PubMed  Google Scholar 

  • Wade D (2005) Cannabis use and schizophrenia. Am J Psychiatry 162(2):401

    Article  PubMed  Google Scholar 

  • Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A (2001) The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 20:407–416

    Article  Google Scholar 

  • West SG (2008) Delusional disorder. In: Loue S, Sajatovic M (eds) Encyclopedia of aging and public health. Springer, New York

    Google Scholar 

  • Winklbaur L, Ebner N, Sachs G, Thau K, Fischer G (2006) Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci 8:37–43

    PubMed Central  PubMed  Google Scholar 

  • Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679

    Article  CAS  PubMed  Google Scholar 

  • Wright S, Gournay K, Glorney E, Thornicroft G (2000) Dual diagnosis in the suburbs: prevalence, need, and in-patient service use. Soc Psychiatry Psychiatr Epidemiol 35:297–304

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Translational Medicine, University of Milano-Bicocca, Milano, Italy

    Daniele Carretta, Massimo Clerici & Francesco Bartoli

  2. UCL Division of Psychiatry, Faculty of Brain Sciences, University College London, 2nd Floor, Charles Bell House, 67-73 Riding House Street, London, W1W 7EJ, UK

    Giuseppe Carrà

Authors
  1. Daniele Carretta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Clerici
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Bartoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Carrà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Carretta .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Alberta Gambling Research Institute University of Calgary, Calgary, Alberta, Canada

    Nady el-Guebaly

  2. Faculty of Brain Sciences UCL Division of Psychiatry, University College London, London, United Kingdom

    Giuseppe Carrà

  3. Division of Alcoholism & Drug Abuse, New York University School of Medicine, New York, New York, USA

    Marc Galanter

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this entry

Cite this entry

Carretta, D., Clerici, M., Bartoli, F., Carrà, G. (2015). Psychotic Disorders and Substance Use Disorders. In: el-Guebaly, N., Carrà, G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_94

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5322-9_94

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5321-2

  • Online ISBN: 978-88-470-5322-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation